10:15 AM EST - BriaCell Therapeutics Corp. : Announces a manufacturing arrangement with FUJIFILM Biotechnologies California, a leading contract development and manufacturing organization (CDMO) specializing in cell therapies, to support the ongoing pivotal Phase 3 clinical development and potential future commercial supply of BriaCell’s lead clinical candidate, Bria-IMT, an off-the-shelf allogenic cell therapy. BriaCell Therapeutics Corp.
shares T.BCT are trading up $0.32 at $5.54.
